Sachpekidis, Christos
Larribère, Lionel
Kopp-Schneider, Annette
Hassel, Jessica C.
Dimitrakopoulou-Strauss, Antonia
Article History
Received: 3 July 2018
Accepted: 23 November 2018
First Online: 26 November 2018
Compliance with ethical standards
:
: Jessica C. Hassel received honoraria for talks and travel expenses from Bristol-Myers Squibb (BMS), Merck, Sharp & Dohm (MSD), Roche, Novartis, Pfizer and is a member of an advisory board for MSD and Amgen. The other authors declare that they have no conflict of interest.
: The presented results are part of the study entitled “Quantification of 18F-FDG kinetics with 4D PET-CT in patients with melanoma stage IV”, which was approved by the Ethical Committee of the University of Heidelberg (Ethikvotum: S-107 /2012—Ethical Committee 1 of the University of Heidelberg) and the Federal Office for Radiation Protection (Bundesamt für Strahlenschutz; BfS: Z5- 22463 / 2 2012a-016). This study does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study. The patient presented in Fig. InternalRef removed agreed to the publication of this figure.